(VIANEWS) – Erie Indemnity Company (ERIE), Dolby Laboratories (DLB), Novo Nordisk A/S (NVO) are the highest payout ratio stocks on this list.
We have collected information concerning stocks with the highest payout ratio up to now. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. Erie Indemnity Company (ERIE)
79.16% Payout Ratio
Erie Indemnity Company operates as a managing attorney-in-fact for the subscribers at the Erie Insurance Exchange in the United States. The company provides sales, underwriting, policy issuance, and renewal services for the policyholders on behalf of the Erie Insurance Exchange. It also offers sales related services, including agent compensation, and sales and advertising support services; and underwriting services comprise underwriting and policy processing; and other services consist of customer services and administrative support services, as well as information technology services. Erie Indemnity Company was incorporated in 1925 and is based in Erie, Pennsylvania.
Earnings Per Share
As for profitability, Erie Indemnity Company has a trailing twelve months EPS of $5.71.
PE Ratio
Erie Indemnity Company has a trailing twelve months price to earnings ratio of 40.24. Meaning, the purchaser of the share is investing $40.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.4%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.2%, now sitting on 2.84B for the twelve trailing months.
2. Dolby Laboratories (DLB)
54.84% Payout Ratio
Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications.; AVC, a digital video codec with high bandwidth efficiency used in media devices; Dolby AC-4, an audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and a range of media devices. Its audio technologies also include Dolby Digital, a digital audio coding technology that provides multichannel sound to applications; Dolby Digital Plus, a digital audio coding technology that offers audio transmission for a range of media applications and devices; Dolby TrueHD, a digital audio coding technology providing encoding for media application; Dolby Vision, an imaging technology for cinema and media devices; Dolby Voice, an audio conferencing technology; and HEVC, a digital video codec with high bandwidth efficiency to support for media devices. In addition, the company designs and manufactures digital cinema servers, cinema processors, amplifiers, loudspeakers, hardware components, video conferencing solutions, and other products for the cinema, television, broadcast, communication, and entertainment industries. Further, it offers various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, cinema operators, broadcasters, and video game designers. It sells its products directly to the end users, as well as through dealers and distributors worldwide. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.
Earnings Per Share
As for profitability, Dolby Laboratories has a trailing twelve months EPS of $1.86.
PE Ratio
Dolby Laboratories has a trailing twelve months price to earnings ratio of 45.76. Meaning, the purchaser of the share is investing $45.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.43%.
Yearly Top and Bottom Value
Dolby Laboratories’s stock is valued at $85.11 at 20:23 EST, under its 52-week high of $88.06 and way above its 52-week low of $61.55.
Revenue Growth
Year-on-year quarterly revenue growth declined by 4.8%, now sitting on 1.24B for the twelve trailing months.
Moving Average
Dolby Laboratories’s value is above its 50-day moving average of $83.15 and way above its 200-day moving average of $75.01.
Sales Growth
Dolby Laboratories’s sales growth is 4.8% for the ongoing quarter and 5% for the next.
3. Novo Nordisk A/S (NVO)
45.42% Payout Ratio
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Earnings Per Share
As for profitability, Novo Nordisk A/S has a trailing twelve months EPS of $3.64.
PE Ratio
Novo Nordisk A/S has a trailing twelve months price to earnings ratio of 46.33. Meaning, the purchaser of the share is investing $46.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 72%.
Volume
Today’s last reported volume for Novo Nordisk A/S is 1005820 which is 28.97% below its average volume of 1416070.
4. The Cushing MLP Total Return Fund (SRV)
35.91% Payout Ratio
Cushing MLP Total Return Fund is a closed-ended balanced mutual fund launched by Swank Capital, LLC. The fund is managed by Swank Energy Income Advisors L.P. It invests in the public equity and fixed income markets across the globe with a focus in United States. The fund typically invests in MLPs, Other Natural Resource Companies, and global commodities. It primarily invests in the securities of MLPs, other equity securities, debt securities, and securities of non-U.S. issuers employing a fundamental analysis. Cushing MLP Total Return Fund was formed on May 23, 2007 and is domiciled in Dallas.
Earnings Per Share
As for profitability, The Cushing MLP Total Return Fund has a trailing twelve months EPS of $8.27.
PE Ratio
The Cushing MLP Total Return Fund has a trailing twelve months price to earnings ratio of 4.05. Meaning, the purchaser of the share is investing $4.05 for every dollar of annual earnings.
Yearly Top and Bottom Value
The Cushing MLP Total Return Fund’s stock is valued at $33.47 at 20:23 EST, way under its 52-week high of $38.00 and way above its 52-week low of $26.24.
Moving Average
The Cushing MLP Total Return Fund’s worth is under its 50-day moving average of $33.98 and under its 200-day moving average of $33.70.
